CEREBRAL ANGIOGRAPHY MARKET

INTRODUCTION

 Cerebral angiography is a medical imaging procedure used to examine the blood arteries in the brain. It is also known as cerebral arteriography or cerebral angiogram. It entails injecting a contrast dye into the blood vessels and then collecting X-ray images to offer precise information on the blood flow and structure of the blood vessels in the brain. This method aids in the diagnosis of numerous vascular problems and brain illnesses.

The patient may be required to fast for a period of time prior to the treatment, and they will be questioned about any allergies to drugs or contrast dyes. The medical team will also do any necessary blood tests and assess the patient's medical history. The patient is normally awake but drugged during the surgery.

Cerebral angiography is an invasive treatment with hazards such as hemorrhage, infection, and allergic reactions to the contrast dye. However, in cases of complex vascular disorders affecting the brain, it is frequently a vital tool for correct diagnosis and therapy planning. Less invasive imaging techniques such as CT angiography and MR angiography have grown in popularity, although they may not provide the same level of information as standard cerebral angiography.

As the contrast dye flows through the blood arteries in the brain, X-ray images are taken. These images provide real-time information regarding blood flow, blockages, aneurysms, and other blood vessel anomalies. Following the treatment, the X-ray images are meticulously examined by a radiologist or other specialized medical practitioner.

CEREBRAL ANGIOGRAPHY MARKET SIZE AND FORECAST

The Global Cerebral angiography market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

CEREBRAL ANGIOGRAPHY MARKETRECENT DEVELOPMENT

Robotic cerebral angiography with the CorPath GRX Robotic System is safe and simple to learn even for inexperienced users. However, technological constraints such as a limited working length and inability to support 0.035" wires may limit its widespread use in clinical practice. There were no notable consequences associated with the use of the robotic system, such as stroke, arterial dissection, hemorrhage, or the creation of a pseudoaneurysm at the access site.

Using the robotic system, 88 of 113 (77.9%) cases were successfully performed without the need for unanticipated manual conversion. The main reasons for unanticipated manual conversion were complex anatomy, technical difficulties with the bedside robotic cassette, and hubbing out of the robotic system due to short working length. 

THISCEREBRAL ANGIOGRAPHY MARKETREPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many Cerebral angiography are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global Cerebral angiography and key vendor selection criteria
3. Where is the Cerebral angiography manufactured? What is the average margin per unit?
4. Market share of Global Cerebral angiography market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global Cerebral angiography in-house
6. key predictions for next 5 years in Global Cerebral angiography market
7. Average B-2-B Cerebral angiography market price in all segments
8. Latest trends in Cerebral angiography market, by every market segment
9. The market size (both volume and value) of the Cerebral angiography market in 2024-2030 and every year in between?
10. Production breakup of Cerebral angiography market, by suppliers and their OEM relationship